Total Payments
$632,441
2024 Payments
$562,112
Companies
19
Transactions
95
Medicare Patients
1,082
Medicare Billing
$519,570
Payment Breakdown by Category
Consulting$542,395 (85.8%)
Other$64,000 (10.1%)
Travel$23,722 (3.8%)
Food & Beverage$2,324 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $542,395 | 9 | 85.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $64,000 | 3 | 10.1% |
| Travel and Lodging | $23,722 | 14 | 3.8% |
| Food and Beverage | $2,324 | 69 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $319,150 | 23 | $0 (2024) |
| UCB, Inc. | $238,108 | 4 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $67,079 | 7 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $4,250 | 1 | $0 (2024) |
| Allergan, Inc. | $2,154 | 7 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $671.04 | 22 | $0 (2024) |
| Janssen Biotech, Inc. | $257.28 | 3 | $0 (2024) |
| ABBVIE INC. | $251.79 | 8 | $0 (2024) |
| Merz North America, Inc. | $248.80 | 6 | $0 (2023) |
| GENZYME CORPORATION | $62.90 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $562,112 | 40 | Incyte Corporation ($319,109) |
| 2023 | $67,084 | 7 | Sun Pharmaceutical Industries Inc. ($66,974) |
| 2022 | $159.20 | 4 | Merz North America, Inc. ($159.20) |
| 2021 | $154.31 | 7 | Novartis Pharmaceuticals Corporation ($72.49) |
| 2020 | $2,151 | 5 | Allergan, Inc. ($2,082) |
| 2019 | $497.15 | 15 | Novartis Pharmaceuticals Corporation ($348.59) |
| 2018 | $98.11 | 5 | Almirall LLC ($35.95) |
| 2017 | $184.43 | 12 | Allergan Inc. ($55.19) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | Incyte Corporation | OPZELURA (Drug) | Consulting Fee | Cash or cash equivalent | $100,000.00 | General |
| Category: Dermatology | ||||||
| 10/10/2024 | Incyte Corporation | OPZELURA (Drug) | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: Dermatology | ||||||
| 10/10/2024 | Incyte Corporation | OPZELURA (Drug) | Travel and Lodging | Cash or cash equivalent | $2,756.58 | General |
| Category: Dermatology | ||||||
| 10/10/2024 | Incyte Corporation | OPZELURA (Drug) | Travel and Lodging | Cash or cash equivalent | $1,650.47 | General |
| Category: Dermatology | ||||||
| 10/10/2024 | Incyte Corporation | OPZELURA (Drug) | Travel and Lodging | Cash or cash equivalent | $663.80 | General |
| Category: Dermatology | ||||||
| 10/10/2024 | Incyte Corporation | OPZELURA (Drug) | Travel and Lodging | Cash or cash equivalent | $331.17 | General |
| Category: Dermatology | ||||||
| 10/10/2024 | Incyte Corporation | OPZELURA (Drug) | Travel and Lodging | Cash or cash equivalent | $232.16 | General |
| Category: Dermatology | ||||||
| 10/10/2024 | Incyte Corporation | OPZELURA (Drug) | Travel and Lodging | Cash or cash equivalent | $188.29 | General |
| Category: Dermatology | ||||||
| 10/10/2024 | Incyte Corporation | OPZELURA (Drug) | Travel and Lodging | Cash or cash equivalent | $163.29 | General |
| Category: Dermatology | ||||||
| 10/10/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $67.72 | General |
| Category: Dermatology | ||||||
| 10/10/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $17.63 | General |
| Category: Dermatology | ||||||
| 10/07/2024 | UCB, Inc. | — | Consulting Fee | Cash or cash equivalent | $225,000.00 | General |
| 09/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Diabetes Care | ||||||
| 08/28/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Diabetes Care | ||||||
| 08/19/2024 | UCB, Inc. | — | Travel and Lodging | In-kind items and services | $8,600.00 | General |
| 08/17/2024 | UCB, Inc. | — | Travel and Lodging | In-kind items and services | $2,396.95 | General |
| 08/17/2024 | UCB, Inc. | — | Travel and Lodging | In-kind items and services | $2,110.95 | General |
| 07/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Immunology | ||||||
| 06/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $33.88 | General |
| Category: IMMUNOLOGY | ||||||
| 06/11/2024 | Incyte Corporation | OPZELURA (Drug) | Consulting Fee | Cash or cash equivalent | $100,000.00 | General |
| Category: Dermatology | ||||||
| 06/11/2024 | Incyte Corporation | OPZELURA (Drug) | Consulting Fee | Cash or cash equivalent | $100,000.00 | General |
| Category: Dermatology | ||||||
| 06/11/2024 | Incyte Corporation | OPZELURA (Drug) | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: Dermatology | ||||||
| 06/11/2024 | Incyte Corporation | OPZELURA (Drug) | Consulting Fee | Cash or cash equivalent | $1,075.00 | General |
| Category: Dermatology | ||||||
| 06/11/2024 | Incyte Corporation | OPZELURA (Drug) | Travel and Lodging | Cash or cash equivalent | $982.54 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 299 | 384 | $475,470 | $144,612 |
| 2022 | 5 | 203 | 244 | $297,879 | $94,945 |
| 2021 | 7 | 326 | 428 | $345,928 | $169,200 |
| 2020 | 7 | 254 | 306 | $233,444 | $110,813 |
Total Patients
1,082
Total Services
1,362
Medicare Billing
$519,570
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 123 | 147 | $228,291 | $73,149 | 32.0% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 77 | 130 | $122,070 | $44,093 | 36.1% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 20 | 23 | $33,465 | $11,706 | 35.0% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 44 | 48 | $56,976 | $9,082 | 15.9% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 19 | 20 | $20,140 | $3,803 | 18.9% |
| 13131 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 1.1-2.5 cm | Office | 2023 | 16 | 16 | $14,528 | $2,779 | 19.1% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 87 | 106 | $154,809 | $54,619 | 35.3% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 45 | 58 | $52,439 | $20,095 | 38.3% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2022 | 40 | 47 | $52,149 | $8,974 | 17.2% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2022 | 15 | 15 | $21,262 | $7,992 | 37.6% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2022 | 16 | 18 | $17,220 | $3,264 | 19.0% |
| 17311 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks) | Office | 2021 | 124 | 172 | $167,872 | $88,868 | 52.9% |
| 17312 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals | Office | 2021 | 75 | 116 | $75,400 | $40,141 | 53.2% |
| 13132 | Repair of wound (2.6 to 7.5 centimeters) of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, and/or feet | Office | 2021 | 56 | 67 | $49,044 | $13,778 | 28.1% |
| 17313 | Removal and microscopic examination of growth of the trunk, arms, or legs (first stage, up to 5 tissue blocks) | Office | 2021 | 24 | 25 | $22,300 | $12,606 | 56.5% |
| 14060 | Tissue transfer repair of wound (10 sq centimeters or less) of eyelids, nose, ears, and/or lips | Office | 2021 | 12 | 12 | $12,432 | $7,811 | 62.8% |
| 13121 | Repair of wound (2.6 to 7.5 centimeters) of scalp, arms, and/or legs | Office | 2021 | 21 | 22 | $12,188 | $3,836 | 31.5% |
| 13131 | Repair of wound (1.1 to 2.5 centimeters) of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, and/or feet | Office | 2021 | 14 | 14 | $6,692 | $2,160 | 32.3% |
| 17311 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks) | Office | 2020 | 96 | 116 | $113,216 | $58,913 | 52.0% |
| 17312 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals | Office | 2020 | 46 | 66 | $42,900 | $22,497 | 52.4% |
| 17313 | Removal and microscopic examination of growth of the trunk, arms, or legs (first stage, up to 5 tissue blocks) | Office | 2020 | 28 | 28 | $24,976 | $14,356 | 57.5% |
| 13132 | Repair of wound (2.6 to 7.5 centimeters) of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, and/or feet | Office | 2020 | 38 | 45 | $32,940 | $8,910 | 27.0% |
| 13121 | Repair of wound (2.6 to 7.5 centimeters) of scalp, arms, and/or legs | Office | 2020 | 19 | 21 | $11,634 | $3,472 | 29.8% |
| 13131 | Repair of wound (1.1 to 2.5 centimeters) of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, and/or feet | Office | 2020 | 13 | 13 | $6,214 | $1,974 | 31.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 14 | 17 | $1,564 | $690.94 | 44.2% |
About Dr. Sandra Rebish, MD
Dr. Sandra Rebish, MD is a MOHS-Micrographic Surgery healthcare provider based in Upland, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1235252289.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandra Rebish, MD has received a total of $632,441 in payments from pharmaceutical and medical device companies, with $562,112 received in 2024. These payments were reported across 95 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($542,395).
As a Medicare-enrolled provider, Rebish has provided services to 1,082 Medicare beneficiaries, totaling 1,362 services with total Medicare billing of $519,570. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Dermatology
- Location Upland, CA
- Active Since 04/06/2007
- Last Updated 01/20/2023
- Taxonomy Code 207ND0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1235252289
Products in Payments
- OPZELURA (Drug) $319,150
- Winlevi (Drug) $66,974
- TREMFYA (Drug) $4,478
- COSENTYX (Biological) $542.48
- Humira (Biological) $129.17
- COSENTYX (Drug) $106.64
- RINVOQ (Biological) $70.56
- FREESTYLE LIBRE 3 (Device) $41.77
- Veltin (Drug) $35.95
- REMICADE (Biological) $29.22
- Finacea (Drug) $23.35
- SKYRIZI (Biological) $22.22
- ENSTILAR (Drug) $18.25
- BOTOX (Biological) $16.17
- ACZONE (Drug) $15.98
- BLU-U (Device) $15.72
- DUPIXENT (Biological) $15.49
- EUCRISA (Drug) $14.10
- VALCHLOR MECHLORETHAMINE (Drug) $13.46
- BOTOX COSMETIC (Biological) $12.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.